Legato Capital Management LLC Sells 1,193 Shares of Perrigo Company plc (NYSE:PRGO)

Legato Capital Management LLC lowered its stake in Perrigo Company plc (NYSE:PRGOFree Report) by 10.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,376 shares of the company’s stock after selling 1,193 shares during the period. Legato Capital Management LLC’s holdings in Perrigo were worth $267,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of PRGO. Franklin Resources Inc. acquired a new stake in Perrigo in the third quarter valued at about $3,717,000. Foundry Partners LLC acquired a new stake in Perrigo in the third quarter valued at about $7,111,000. Barclays PLC boosted its stake in Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company’s stock valued at $3,160,000 after buying an additional 37,268 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Perrigo by 65.1% in the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company’s stock valued at $14,190,000 after buying an additional 213,221 shares in the last quarter. Finally, Citigroup Inc. boosted its stake in Perrigo by 94.1% in the third quarter. Citigroup Inc. now owns 151,520 shares of the company’s stock valued at $3,974,000 after buying an additional 73,457 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Insider Transactions at Perrigo

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the transaction, the director now directly owns 5,409 shares in the company, valued at $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by corporate insiders.

Perrigo Stock Performance

Shares of PRGO stock opened at $24.48 on Friday. The business’s 50-day moving average price is $25.25 and its 200-day moving average price is $26.38. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.46. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of -20.93 and a beta of 0.54. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. StockNews.com raised Perrigo from a “hold” rating to a “buy” rating in a research note on Monday, February 10th. Finally, Piper Sandler lowered Perrigo from an “overweight” rating to a “neutral” rating and cut their price target for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $35.00.

Read Our Latest Stock Analysis on PRGO

Perrigo Company Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGOFree Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.